Revenue for the quarter was $71.43 million with operating income of $2.05 million.
The Cambridge, Massachusetts (MA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $352.65 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.